Edwards Lifesciences Corporation (Edwards or 'the company') is the global medical technology leader in patient-focused innovations for structural heart disease and critical illness. The company focuses on cardiac surgery, critical care, and vascular therapies products and services. It operates in the US, Europe, Japan and other parts of the world. The company manufactures and markets three main product lines: transcatheter heart valves; surgical heart valve therapy; and critical care. Edwards' transcatheter heart valves product line includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to traditional open-heart surgery. The Edwards Sapien, Edwards Sapien XT and Edwards Sapien 3 transcatheter aortic heart valves are used for the nonsurgical replacement of heart valves.As of December 31, 2016, the transcatheter heart valve therapy product line recorded revenues of $1,628.5 million, an increase of 38% over FY2015. The company's surgical heart valve therapy product line includes tissue heart valves and heart valve repair products such as annuloplasty rings and systems, for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a line of products used during minimally invasive aortic heart valve system used during cardiopulmonary bypass procedures and smaller incisions.The surgical heart valve therapy product line recorded revenues of $774.9 million in FY2016, a decrease of 1.3% compared to FY2015. The company's critical care product line includes advanced monitoring systems, pulmonary artery catheters and disposable pressure monitoring devices. The company develops and markets hemodynamic monitoring systems for measuring heart function in surgical and intensive care settings. Edwards' hemodynamic monitoring technologies are utilized before, during and after open-heart, major vascular, major abdominal, neurological and orthopedic surgical procedures, as well as for acutely ill patients with conditions such as sepsis, acute respiratory distress syndrome and multi-organ failure. Edwards manufactures and markets the Swan-Ganz line of pulmonary artery catheters, and the PreSep continuous venous oximetry catheter for measuring central venous oxygen saturation. In addition, Edwards' hemodynamic monitoring product line also includes the minimally invasive FloTrac system and the noninvasive ClearSight system. Its VolumeView sensor-catheter set measures a critically ill patient's volumetric hemodynamic parameters, while the EV1000 touch-screen clinical monitoring platform displays a patient's physiologic status. Edwards also offers disposable pressure monitoring devices and innovative closed blood sampling systems to protect both patients and clinicians from the risk of infection. Under the critical care product line, Edwards also manufactures and sells a variety of products used to treat endolumenal occlusive disease including the Fogarty line of embolectomy catheters. The critical care product line recorded revenues of $560.3 million in FY2016, anincrease of 6% compared to FY2015. Geographically, the US, Edwards’ largest geographic market, accounted for 54.5% of the total revenues in FY2016. Revenues from the US reached $1,615.7 million in FY2016, an increase of 27.9% over FY2015.Japan accounted for 10.4% of the total revenues in FY2016. Revenues from Japan reached $309.3 million in FY2016, anincrease of 25.6% compared to FY2015. Europe accounted for 25.3% of the total revenues in FY2016. Revenues from Europe reached $749 million in FY2016, anincrease of 4.4% compared to FY2015. Rest of the world accounted for 9.8% of the total revenues in FY2016. Revenues from rest of the world reached $289.7 million in FY2016, anincrease of 8.4% compared to FY2015.

Scope of the Report

-- About the Company - Historical Details, Current Ownership Structure and basic overview of Edwards Lifesciences Corporation in terms of revenue, net income, and operating income.

-- Financials - Details about Edwards Lifesciences Corporation listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.

-- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.

-- Company SWOT Analysis - Outlines Edwards Lifesciences Corporation’s strengths, weaknesses, and opportunities and threats facing the company.

-- Recent Developments - Showcases Edwards Lifesciences Corporation’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.

-- Strategic Evaluation - Provides an overview of Edwards Lifesciences Corporation’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.

-- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.

Key Questions Answered

-- What domain does Edwards Lifesciences Corporation operate and what are key points about it?

-- What is the product / service portfolio of Edwards Lifesciences Corporation?

-- How has Edwards Lifesciences Corporation performed financially from the 2013?

-- How does Edwards Lifesciences Corporation rank among its peers in terms of revenue and market share?

-- What are Edwards Lifesciences Corporation strengths and weaknesses and what opportunities and threats does it face?

-- What are Edwards Lifesciences Corporation’s main growth strategies and how successful has the company been at implementing them?

-- What is the in-house technical capability of Edwards Lifesciences Corporation? Where does it procure / outsource it?

Reasons to buy

-- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own

-- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost

-- 12 hour delivery time fulfilling your urgent requests as per your requirement

-- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics